Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000058221) titled 'Elucidation of Energy Metabolism Mechanisms in Parkinson Disease Using Doubly Labeled Water' on Aug. 1.
Study Type: Interventional
Study Design:
Single arm Non-randomized
Primary Sponsor: International University of Health and Welfare
Condition:
Parkinson disease
Intervention:
On the first day of the study, participants will ingest doubly labeled water containing stable isotopes of oxygen and hydrogen. The volume administered will be approximately 1.5 g per kilogram of body weight, depending on the each body size.
Recruitment Status: Not Recruiting
Phase: Not selected
Date of First Enrollment: 2025/...